(1) With some pertinent exceptions, dermatomycosis is typically confined to the superficial keratinized tissue and, thus, can often be treated with topical antifungal medications.(2) It is effective against both dermatophytosis and dermatomycosis infections.(3) The efficacy of unspecific and specific immune responses decides on the development of dermatomycoses in domestic animals.(4) All clinical specimens from cats and dogs with skin disease, suggesting dermatomycoses were included.(5) The regulatory dossier contains data on around 3,000 patients who have been treated for dermatomycoses in Phase II and Phase III clinical trials in Japan and Europe.
